Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan in Irinotecan-Refractory SCLC
NCT00502762Phase 2Unknown
- Sponsor
- Gachon University Gil Medical Center
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan in small cell lung cancer (SCLC), sponsored by Gachon University Gil Medical Center. Primary endpoint: Response Rate. Status: unknown.
02
Drugs
topotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00502762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502762.